Periodontal Disease Treatment Market
Report ID: SQMIG35I2765
Report ID: SQMIG35I2765
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35I2765 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
176
|Figures:
79
Global Periodontal Disease Treatment Market size was valued at USD 8.3 Billion in 2024 and is poised to grow from USD 8.9 Billion in 2025 to USD 15.52 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).
The periodontal disease treatment market growth is driven by higher rates of chronic periodontitis and aging populations, which naturally adds pressure on dental services. As a whole market, it covers preventive offerings, non-surgical plus surgical therapies, diagnostic instruments, and pharmaceuticals, and it basically matters since untreated periodontal disease can end in tooth loss and also spills over into systemic problems like cardiovascular disease and worsening of diabetes.
On top of that tech uptake, one growth driver is broader screening and more integrated medical and dental pathways, because it helps identify a treatable group and care teams can coordinate around diabetes and cardiovascular risk. That linkage then pushes payers and providers to put more resources into chairside diagnostics and locally delivered antimicrobial options, like clinics moving toward Arestin to shorten treatment intervals while hospitals fold periodontal assessment into diabetes management flows. Meanwhile, regulatory nods for regenerative biologics let clinicians deliver more predictable bone and tissue reconstruction, which boosts demand for surgical interventions and opens room for manufacturers to bundle devices with drug solutions.
AI is improving diagnostic accuracy in periodontal disease by stitching together automated image analysis, pattern recognition, and organized clinical data, it helps surface bone loss, gingival recession, and small changes that can be overlooked during a standard visual check. Right now, the state of things is that AI is being folded quickly into radiographic interpretation and day to day clinical routines, in private practices and dental service organizations. This improves how consistent assessments are, and it supports tighter treatment planning. Adoption is partly fueled by vendors embedding AI into intraoral scanners, imaging platforms, and practice management systems, so that the documentation gets more standardized and referrals become clearer, with less back and forth.
Examples such as AI that flags bone changes, automates perio charting, and produces integrated reporting that makes clinical decisions faster. Planet DDS, February 2026, for instance, launched AI Voice Perio to automate periodontal charting and capture structured findings during the exam, which supports steadier diagnosis and trims documentation variation. By turning periodontal data into something more reliable and easier to act on, this innovation helps dental groups scale care delivery and improve clinical throughput across networks.
Market snapshot - (2026-2033)
Global Market Size
USD 8.3 Billion
Largest Segment
Scaling & Root Planing
Fastest Growth
Laser Therapy
Growth Rate
7.2% CAGR
To get more insights on this market click here to Request a Free Sample Report
The global periodontal disease treatment market is segmented by treatment type, disease type, drug class, end user, route of administration, patient group and region. Based on treatment type, the market is segmented into Antibiotic Therapy, Scaling & Root Planing, Surgical Treatment, Regenerative Therapy, Laser Therapy and Others. Based on disease type, the market is segmented into Gingivitis, Chronic Periodontitis, Aggressive Periodontitis and Others. Based on drug class, the market is segmented into Antimicrobial Agents, Anti-Inflammatory Agents, Host Modulation Agents and Others. Based on end user, the market is segmented into Dental Clinics, Hospitals and Academic & Research Institutes. Based on route of administration, the market is segmented into Local Delivery, Oral and Injectable. Based on patient group, the market is segmented into Adult, Geriatric and Pediatric. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
As per the periodontal disease treatment market analysis, The Scaling & Root Planing segment dominates since it acts as that foundational non surgical approach clinicians lean on, to strip away subgingival biofilm and calculus , while also lowering pocket depths. There’s strong clinical support, a lot of clinician familiarity, and steady predictable results that keep it sitting at the center of periodontal treatment protocols. That in turn makes it a routine step, which then keeps generating steady demand for maintenance care adjunctive therapies, and instruments that fit neatly into day to day periodontal workflows, and all of this also aligns with payer expectations and guidance.
Meanwhile, Laser Therapy is emerging as the fastest-growing area in periodontal care, mainly because recent technological advances enable minimally invasive pocket decontamination and it tends to be better received by patients. More clinics adopting it, ongoing product upgrades, and active investment from device manufacturers are pushing expansion. As a result, new practice models and broader commercial openings are witnessed.
According to the periodontal disease treatment market forecast, the Antimicrobial Agents segment leads, largely because broad-spectrum antimicrobials and locally delivered antibiotics have long been the standard therapeutic backbone for addressing the bacterial causes of periodontal disease. Long standing clinical routines, strong familiarity among physicians and dentists, and wide pharmaceutical availability all support consistent prescribing, and they keep antimicrobial options firmly inside treatment pathways. When outcomes are dependable, and when these options also work alongside standard mechanical therapies, the demand stays solid across different care environments. It also helps the broader ecosystem of delivery devices, formulations, and related adjunctive products keep moving.
Still, Host Modulation Agents are showing the strongest growth energy right now , because newer research keeps pointing toward therapies that focus on inflammatory pathways. Progress in biologics , biomarker guided decision making, plus more defined adjunctive approvals are helping drive clinical uptake. This shift widens the range of therapeutic choices, encourages combined regimens, and creates new commercial chances for specialty pharmaceuticals and more personalized periodontal care models.
To get detailed segments analysis, Request a Free Sample Report
As per the periodontal disease treatment market regional forecast, North America is leading the market, because there’s this stitched together mix of clinical know how , strong reimbursement rules, and people actually adopting advanced dental technologies fast. A lot of research and development work sits around academic centers and medical device makers, so see faster movement from early studies into minimally invasive therapies, plus digital solutions that actually get used. Then the healthcare system itself helps too, since it can support multidisciplinary care paths where preventative dentistry, specialty periodontal services, and extra medical management are somehow blended together. Market access also feels smoother due to professional associations and care guidelines, that push a more standardized approach and earlier intervention. Patients are more aware of oral and systemic health links, and at the same time there’s favorable funding for clinical centers, plus trained dental specialists are more widely available, so demand stays steady for new procedures and full treatment packages across the region. Industry and clinicians also connect through collaborative networks, which strengthens commercialization routes and day to day service delivery, in a way that keeps momentum going.
United States Periodontal Disease Treatment Market
In the United States, the periodontal disease treatment sector is shaped by concentrated research momentum, broad access to specialist clinicians, and quick adoption of new surgical as well as non surgical therapies. Private practices and academic centers team up to polish treatment protocols, while payer models and professional guidelines end up steering how quickly clinicians take up the newer approaches. Patient pressure for both aesthetic and functional results pushes regenerative techniques and laser assisted therapies into broader use, and industry partnerships back trials and wider diffusion.
Canada Periodontal Disease Treatment Market
In Canada, universal healthcare influences how services are delivered, and it’s also supported by strong academic dental programs and prevention minded networks that route patients to specialists when needed. Evidence based periodontal protocols tend to be adopted through teamwork initiatives linking public clinics with private practices. Technology adoption leans toward cost effective lasers and regenerative options that fit real clinical needs, not just the most advanced version of everything. Workforce placement, along with continuing education, helps protect patient access and supports treatment quality and outcomes.
Europe’s rapid periodontal disease treatment market penetration expansion comes from a convergence of factors like rising public and professional awareness around oral systemic connections. There are also coordinated regulatory frameworks in place that encourage safer introduction of advanced therapies, plus a dense network of specialized dental clinics, especially across urban centers. Research organizations, device manufacturers, and clinical societies collaborate to build evidence and develop guidelines. Market momentum is also supported by preventive care models, and in some segments, cross-border reimbursement harmonization is starting to matter. Patients increasingly prefer minimally invasive and regenerative solutions, and that preference helps shape what gets purchased and offered. Strong training programs and growing use of digital dentistry tools also help scale effective care pathways, making the region a major stage for innovation and more refined periodontal practice. Clinician education investments and public screening campaigns lift diagnosis rates, which then stimulates demand for specialist periodontal interventions across different healthcare systems.
Germany Periodontal Disease Treatment Market
In Germany, the periodontal disease treatment market is driven by deliberate clinical research , a large network of dental specialists, and the availability of periodontal services tied to hospitals. Reimbursement structures along with professional guidelines support evidence based protocols. Meanwhile, collaborations between industry and clinics help push device innovation forward. Continuing education, together with regional centers, supports uptake of regenerative techniques and digital treatment planning, so demand holds for both established therapies and newer emerging approaches across the country.
United Kingdom Periodontal Disease Treatment Market
In the United Kingdom, the periodontal disease treatment market shows rapid clinical adoption and rising investment in specialist periodontal services across major cities. Integrated care pathways connect primary dental practices with specialist clinics, while private providers keep expanding what they offer in minimally invasive and aesthetic therapies. Public awareness campaigns and professional networks also speed up diagnosis and referrals. With evidence based protocols and digital treatment planning, clinicians and patients tend to accept regenerative options and adjunctive modalities more readily.
France Periodontal Disease Treatment Market
France’s periodontal disease treatment market has shown emerging momentum, mostly due to deeper integration of specialist periodontal services inside dental networks. Academic research centers work alongside regional clinics, helping validate regenerative approaches and adjunctive therapies in real clinical contexts. Patient interest in minimally invasive care and aesthetic results also pushes adoption along. Policy emphasis on preventive oral health, plus professional development programs, strengthens diagnostic capacity and improves referral pathways. That overall setup helps expand periodontal offerings nationwide.
Asia Pacific is getting more firm in its position by strategic investments in clinical research, some modernization of dental infrastructure, and targeted training programs that basically grow the specialist workforce. At the same time regional manufacturers keep pushing cost effective device solutions that fit real local clinical needs , while academic institutions are doing more joint studies that confirm minimally invasive and regenerative methods. In the city hubs, technology adoption tends to move first, especially digital workflows that tidy up diagnosis and treatment planning , which in turn helps clinics run smoother. Also, a bigger middle class is expecting more, and there is more focus on oral systemic health, so patients are seeking out full periodontal care. Cross border collaborations, international accreditation for clinical programs, plus public private initiatives all add together to widen access and raise periodontal treatment standards across different markets in the region. On top of that, policy reforms in several countries are lining regulatory routes up with international norms, meaning faster entry for new therapies, and clinician exchange programs that speed up skill transfer.
Japan Periodontal Disease Treatment Market
In Japan, the periodontal disease treatment market shows high clinical expectations, with research organizations tightly linked to dental clinics, plus a strong reliance on precise diagnostic tools. The emphasis stays on minimally invasive and regenerative care, supported by hands on clinician education and professional networks. Domestic makers supply materials and instruments that match clinician preferences and routine workflows. Patient interest in thorough oral health, combined with better coordination between dental and medical providers, helps create multidisciplinary care pathways and supports the continued expansion of periodontal services.
South Korea Periodontal Disease Treatment Market
In South Korea, the periodontal disease treatment market is moving forward fast due to digital dentistry adoption, wide clinic networks, and steady innovation from local device manufacturers. Clinicians are building strong capabilities in minimally invasive surgery and regenerative approaches, aided by training programs, and also by international partnerships. Because aesthetic priorities matter, many patients are more willing to pursue advanced options , which lifts uptake. Meanwhile, policy efforts that focus on prevention and healthcare integration improve access and encourage periodontal offerings to develop across the country.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Awareness Of Oral Health
Technological Advancements In Therapies
Limited Reimbursement And Access
Shortage Of Trained Clinicians
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape seems focused around incumbent groups consolidating, and then a more targeted biotech innovation on the side, where deal-making plus product integration becomes the thing that differentiates everyone. Big players tend to stretch their regenerative and digital lineups via acquisitions, mainly for distribution reach, and then partnerships with research institutes help speed up licensing, especially around microbiome concepts and targeted therapies. A few recent things that look like this are Straumann’s move to integrate GalvoSurge, and Dentsply Sirona rolling out regenerative offerings , and together that nudges incumbents toward strategic alliances and more licensing style arrangements.
Top Player’s Company Profile
Recent Developments in the Periodontal Disease Treatment Market
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global periodontal disease treatment market is primarily pushed by a rising prevalence of chronic periodontitis and aging populations, both of which increase demand for dental care. It is also boosted by technological advancements like AI-enhanced diagnostics and regenerative biologics, which can improve detection and outcomes. Still, limited reimbursement and restricted access remain the big restraints, and they limit how many patients actually move forward with advanced therapies. North America continues to lead, mostly because of strong clinical infrastructure, reimbursement frameworks, and fast technology adoption. Scaling & Root Planing remains the dominant treatment segment because it is basically the foundational, evidence-based nonsurgical option that fits routine practice.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 8.3 Billion |
| Market size value in 2033 | USD 15.52 Billion |
| Growth Rate | 7.2% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Periodontal Disease Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Periodontal Disease Treatment Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Periodontal Disease Treatment Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Periodontal Disease Treatment Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Periodontal Disease Treatment Market size was valued at USD 8.3 Billion in 2024 and is poised to grow from USD 8.9 Billion in 2025 to USD 15.52 Billion by 2033, growing at a CAGR of 7.2% during the forecast period (2026-2033).
Competitive landscape is concentrated around incumbent consolidation and targeted biotech innovation, with deal making and product integration driving differentiation. Major groups expand regenerative and digital portfolios through acquisitions for distribution scale, while partnerships with research institutes accelerate licensing of microbiome and targeted therapies. Recent examples include Straumann’s integration of GalvoSurge and Dentsply Sirona’s regenerative product rollouts, which together push incumbents into strategic alliances and licensing arrangements. 'Dentsply Sirona', 'Straumann Group', 'Envista Holdings', 'Coltene', 'GC Corporation', 'Mitsui Chemicals', 'Ivoclar', 'Septodont', 'Sunstar', '3M', 'Henry Schein', 'Zimmer Biomet', 'ZimVie', 'Geistlich Pharma', 'Biolase', 'STERIS', 'Bausch Health Companies', 'EMS Electro Medical Systems', 'Huons', 'Den-Mat Holdings'
Rising public awareness of oral health and periodontal disease has led to earlier recognition of symptoms and greater willingness to seek professional care, which expands demand for diagnostic services and therapeutic interventions. Educational campaigns by dental associations, patient advocacy groups, and media coverage encourage routine dental visits and adherence to treatment regimens, prompting practitioners to adopt advanced treatment modalities. Increased health literacy also fosters acceptance of long-term periodontal management strategies, creating sustained demand for both surgical and nonsurgical products and services across private and public healthcare settings.
Minimally Invasive Therapies: Clinical emphasis is shifting toward techniques and products that reduce tissue trauma, accelerate healing, and improve patient comfort. Manufacturers and clinicians prioritize gentle delivery systems, adjunctive biologics, and regenerative matrices that support conservative management and preserve anatomy. Commercial strategies highlight predictable outcomes, simplified workflows, and stronger patient acceptance, enabling broader adoption across practice settings. This trend stimulates collaboration among device makers, biomaterial developers, and dental networks to refine protocols and expand value propositions focused on long term periodontal stability globally.
Why does North America Dominate the Global Periodontal Disease Treatment Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
